Potomac, MD, United States of America

Michael K Bamat



 

Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 410(Granted Patents)


Location History:

  • Chevy Chase, MD (US) (1993 - 2005)
  • Darnestown, MD (US) (1995 - 2006)
  • Potomac, MD (US) (1997 - 2015)

Company Filing History:


Years Active: 1993-2015

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: Michael K. Bamat: Innovator in Uric Acid Reduction

Introduction: Michael K. Bamat, based in Potomac, MD, has made significant contributions to the field of medicinal chemistry, particularly with respect to the development of compounds that reduce uric acid levels in mammalian subjects. With a total of 34 patents to his name, Bamat has been an influential figure in the quest for effective treatments for conditions related to uric acid.

Latest Patents: Among his most recent patents is a groundbreaking invention focused on compounds and methods for reducing uric acid levels. This patent outlines a unique formulation, described by Formula I, which showcases a variety of configurations to effectively lower uric acid and enhance its excretion. The inventions in this patent target several health conditions, including gout, hyperuricemia, renal dysfunction, and other related ailments. Notably, the compounds described can comprise various substituents, allowing them to be tailored for optimal efficacy in treatment.

Career Highlights: Bamat's career includes tenure at respected companies such as Pro-Neuron, Inc. and Wellstat Therapeutics Corporation, where he contributed his expertise in developing therapeutic innovations. His work has led to significant advancements in the pharmaceutical landscape, particularly in understanding and addressing elevated uric acid levels.

Collaborations: Throughout his career, Bamat has collaborated with esteemed colleagues, including Reid W. von Borstel and Reid Warren von Borstel. Their combined efforts have propelled the research and development of potential solutions for serious health issues, underlining the importance of teamwork in scientific innovation.

Conclusion: Michael K. Bamat stands as a prominent innovator in the pharmaceutical industry, with a focused commitment to addressing the challenges associated with uric acid levels. His extensive patent portfolio and collaborative work reflect his significant contributions to medical science, offering hope and therapeutic solutions for numerous health conditions. Through continued research and innovation, Bamat remains a key player in the ongoing battle against diseases linked to hyperuricemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…